Pyrazole aminopyrimidine derivatives as LRRK2 modulators
US9212173B2 · kind B2 · utility
8Cited by
4References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 3, 2014 |
| Grant date | Dec 15, 2015 |
| Priority date | — |
| Expiry date | Nov 3, 2034 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/506
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Pyrazole compounds that are modulators of LRRK2, methods of making the compounds, and methods for using the compounds for treatment of diseases associated with LRRK2 receptor, such as Parkinson's disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.